These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7577334)

  • 1. Peripheral blood stem cell transplantation.
    Bensinger W
    Cancer Treat Res; 1995; 76():169-93. PubMed ID: 7577334
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the collection efficiency and characteristics of peripheral blood progenitor cells mobilized by G-CSF administration in the steady state versus postmyelosuppressive chemotherapy.
    Masauzi N; Kobayashi N; Suzuki G; Ohizumi H; Ogasawara M; Kiyama Y; Naohara T; Saitoh M; Higa T; Kasai M
    Transplant Proc; 1996 Jun; 28(3):1741-5. PubMed ID: 8658864
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
    Lee WJ; Zimmerman T; Meyers S; Bender JG; Williams SF
    Prog Clin Biol Res; 1994; 389():421-7. PubMed ID: 7535451
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensive chemotherapy with peripheral progenitor stem cell support: experience of the Hematology Department of São João hospital, Oporto, Portugal.
    Príncipe F; Duarte R; Granato C; Parreira MJ; Ribeiro M
    Transplant Proc; 2000 Dec; 32(8):2678-9. PubMed ID: 11134760
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies.
    Sheridan WP; Begley CG; To LB; Grigg A; Szer J; Maher D; Green MD; Rowlings PA; McGrath KM; Cebon J
    Bone Marrow Transplant; 1994 Jul; 14(1):105-11. PubMed ID: 7524904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery.
    Remes K; Matinlauri I; Grenman S; Itälä M; Kauppila M; Pelliniemi TT; Salminen E; Vanharanta R; Rajamäki A
    J Hematother; 1997 Feb; 6(1):13-9. PubMed ID: 9112214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF.
    Hohaus S; Goldschmidt H; Ehrhardt R; Haas R
    Exp Hematol; 1993 Apr; 21(4):508-14. PubMed ID: 7681782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF).
    Bregni M; Siena S; Bonadonna G; Gianni AM
    Eur J Cancer; 1994; 30A(2):235-8. PubMed ID: 7512358
    [No Abstract]   [Full Text] [Related]  

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?
    Ener RA; Meglathery SB; Cuhaci B; Topolsky D; Styler MJ; Crilley P; Brodsky I; Kahn SB; King RS
    Am J Clin Oncol; 2001 Feb; 24(1):19-25. PubMed ID: 11232944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large volume leukapheresis following peripheral blood stem cell mobilization by cyclophosphamide and granulocyte-macrophage colony stimulating factor.
    Safran H; Caguioa P; Tansan S
    Prog Clin Biol Res; 1994; 389():639-42. PubMed ID: 7700930
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
    Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
    Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
    Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days.
    de Kreuk AM; Jonkhoff AR; Zevenbergen A; Hendriks EC; Schuurhuis GJ; Ossenkoppele GJ; Dräger AM; van Oostveen JW; Huijgens PC
    Bone Marrow Transplant; 2001 Jul; 28(2):145-55. PubMed ID: 11509932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapy of patients with malignant lymphoma using G-CSF].
    Asano S
    Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):924-7. PubMed ID: 7525813
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow and peripheral blood hematopoietic stem cell transplantation: focus on autografting.
    Baynes RD; Hamm C; Dansey R; Klein J; Cassells L; Karanes C; Abella E; Peters WP
    Clin Chem; 2000 Aug; 46(8 Pt 2):1239-51. PubMed ID: 10926918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.
    Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Demuynck HM; Link H; Zander A; Barge A
    Lancet; 1996 Feb; 347(8998):353-7. PubMed ID: 8598700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.